Health
Focusing on Cutting-edge Biopharmaceutical Technologies, Boosting the Industry to Achieve Innovation and Development
SHANGHAI, Dec. 25, 2019 /PRNewswire/ -- To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry---bioLIVE China 2020, will be held again at Hall W4 in the SNIEC onJune 22-24, 2020. The exhibition, co-l...
2019-12-25 12:55
2907
ALS Awareness Project Led by an ALS Patient
TOKYO, Dec. 24, 2019 /PRNewswire/ -- The END ALS Association (Representative: Motoi Ito, Tokyo, Japan) announced the launch of their Merry & Bright - EEG Illumination project. The objective of this project is to enable Masahiro "Hiro" Fujita,an ALS patient and founder of the association, who has ...
2019-12-24 21:49
1764
Viva Biotech Awarded 'Top 10 Public Companies'
BEIJING, Dec. 24, 2019 /PRNewswire/ -- The 'Future Healthcare VB 100 Summit' organized by VCBeat and VCBeat Research was held inBeijing. Viva Biotech was invited to the Summit and awarded the 'Top 10 Public Companies 2019' with honor. Dr. David Xu, the Chief Business Officer of Viva Biotech, was ...
2019-12-24 18:18
1486
EpiVax Announces Record Year for Growth in 2019 and Sets New Milestones for 2020
PROVIDENCE, Rhode Island, Dec. 24, 2019 /PRNewswire/ -- EpiVax ("EpiVax, Inc.") continues its record-breaking performance and growth in personnel in 2019 while identifying new milestones to aspire to in 2020. The Business Development team closed 15% more contracts over 2018 and acquired two ne...
2019-12-24 16:35
2093
TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments
The operation will accelerate TOWA's overseas business presence and provide high-quality and value-added generic medicines to patients. OSAKA, Japan and BARCELONA, Spain, Dec. 23, 2019 /PRNewswire/ -- TOWA PHARMACEUTICAL CO.,LTD. (Osaka, Japan) (TOWA) and ESTEVE (Barcelona, Spain) announced toda...
2019-12-23 17:17
1182
WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters
DUBLIN, Dec. 23, 2019 /PRNewswire/ -- December 23, 2019 – WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has received the "Special Awa...
2019-12-23 16:26
2296
Holmusk and NHCS Extend Collaboration to Improve Heart Disease Care
SINGAPORE, Dec. 23, 2019 /PRNewswire/ -- Holmusk and National Heart Centre Singapore announced that they have extended their collaboration agreement to improve care for patients with coronary artery disease using machine learning and data analytics, untilDecember 2020. This will build upon the wo...
2019-12-23 13:43
1928
iView Announces First Patient Treated in Phase 2 Clinical Trial Program Evaluating IVIEW-1201 in Patients with Acute Adenoviral Conjunctivitis
HYDERABAD, India, Dec. 23, 2019 /PRNewswire/ -- iView Therapeutics Inc. today announced that the first patient has been dosed in the Phase 2 IVIEW-1201-01-AIC clinical trial program assessing the efficacy of IVIEW-1201 in patients (age ≥15 years) with Acute Adenoviral Conjunctivitis. First subjec...
2019-12-23 08:42
1865
NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study
LUND, Sweden, Dec. 23, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the completed recruitment of healthy volunteers in the second part of the company's ongoing Phase Ia/b clinical study with candidate drug KL1333, in development for chroni...
2019-12-23 08:33
1348
Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology
Demonstrates Evoke® ECAP-Controlled Closed-Loop SCS Provides Statistically Superior Pain Relief Compared to Open-Loop SCS ARTARMON, Australia, Dec. 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announcedThe Lancet Neurology journal published results from the U.S. P...
2019-12-21 07:48
1739
China's Largest Plasmid and Virus Facility from GenScript was Put into Operation
ZHENJIANG, China, Dec. 20, 2019 /PRNewswire/ -- The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation onDecember 18, 2019. It is a milestone on the path to industrialization of the gene and cell therapy indus...
2019-12-20 22:00
12929
China's Largest Plasmid and Virus Facility from GenScript in Operation
ZHENJIANG, China, Dec. 20, 2019 /PRNewswire/ -- The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation onDecember 18, 2019. It is a milestone on the path to industrialization of the gene and cell therapy indus...
2019-12-20 21:59
2877
InxMed Receives Approval to Initiate Phase I Clinical Trial in China for IN10018
BEIJING, Dec. 20, 2019 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today that the Company has obtained IND (Investigational New Drug) clearan...
2019-12-20 18:21
2397
HISKY, a leader in the innovative detection technology of liver health, launches the new brand iLivTouch
BEIJING, Dec. 20, 2019 /PRNewswire/ -- Recently, Wuxi Hisky Medical Technologies Co., Ltd. (hereinafter referred to as "HISKY") has successfully launched its new brand iLivTouch based on the MigTE technology. "On the increasingly competitive market, cycles of technological innovation are key to ...
2019-12-20 15:49
989
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC
SEONGNAM, South Korea, Dec. 19, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company filed an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) and the Ministry...
2019-12-20 10:19
1286
Hematogenix Announces the Opening of Their Newest Facility in Shanghai, China
TINLEY PARK, Illinois, Dec. 19, 2019 /PRNewswire/ -- Hematogenix® announces the opening of their newest facility inShanghai, China furthering their commitment to be a global leader in the field of cancer research and diagnostic testing. China's growing population is attractive to the pharmaceutica...
2019-12-19 22:07
2092
4G Clinical Launches Innovative Clinical Supply Software Leveraging Natural Language Processing (NLP)
4C Supply™ Empowers Supply Professionals to Build and Analyze Multiple Supply Models Themselves, Providing Speed, Simplicity and Control over Supply Decisions WELLESLEY, Mass., Dec. 19, 2019 /PRNewswire/ -- 4G Clinical today announced the launch of 4C Supply™, a cutting-edge clinical supply optim...
2019-12-19 21:20
1491
Shenzhen signs projects worth RMB 560 billion as it promotes investment globally
SHENZHEN, China, Dec. 19, 2019 /PRNewswire/ -- Shenzhen Global Investment Promotion Conference 2019, hosted by the People's Government of Shenzhen and organized by such government entities as the Development and Reform Commission of Shenzhen Municipality, was held in the southern Chinese city on ...
2019-12-19 21:11
1952
Merck Licenses Foundational CRISPR Integration Technology to Promega
- Gives scientists a new view into natural cell activity, accelerating drug development DARMSTADT, Germany, Dec. 19, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that it has signed a license agreement providingPromega Corp., a global life science manufact...
2019-12-19 21:00
2409
Tessa Therapeutics to Open 90,000 Square Foot Commercial-Scale Cell Therapy Manufacturing Facility in Singapore in 2020
* State-of-the-art manufacturing facility will support clinical and commercial production of cell therapies for thousands of patients annually worldwide * Global commercial-scale facility is designed to comply with cGMP guidelines in the U.S.,Europe and Asia * Facility will integrate digita...
2019-12-19 20:00
1264
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5214
